Shilpa Gupta, Md

This early-stage study is testing whether a new targeted drug, sacituzumab govitecan, can be safely combined with precise radiation therapy. The goal is to control muscle-invasive bladder cancer while allowing patients to keep their bladder, avoiding surgical removal. The study w…